Medical Procedure News

RSS

Bariatric surgery rates rise among adolescents

According to recent surveys more and more adolescents need bariatric surgery for morbid obesity. This procedure was earlier reserved only for adults. Researchers say that from 2005 to 2007, the rate of gastric banding has jumped nearly seven-fold among youths aged 13 to 20. The process involves placement of a band around the upper part of the stomach using a laparoscope. The study appeared in the journal Pediatrics.

21 Sep 2010

New interventional technique effective for controlling hepatic arterial hemorrhage after PD

Delayed hepatic arterial hemorrhage after pancreaticoduodenectomy (PD) is not a common but a fatal complication, occurring in 7% of all patients. Its ideal management remains unclear and controversial. A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. The authors reported the clinical outcome of 9 patients with life-threatening hemorrhage from a ruptured hepatic artery pseudoaneurysm after PD after treatment with a new interventional technique, namely placement of stent-grafts.

21 Sep 2010

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined.

21 Sep 2010

FG-4592 oral anemia therapy receives CTA approval from SFDA

FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.

21 Sep 2010

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.

21 Sep 2010

Corindus announces clinical results of CorPath 200 System

Corindus Vascular Robotics announced the results of the first clinical study of the CorPath 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.

21 Sep 2010

New body-contouring laser causes fat loss

Stephanie Martinez had one of the most universal desires - to shed a few stubborn inches from her waist, hips and thighs - without harsh diets, needles or other surgical interventions that require staying at home and taking time off from work.

20 Sep 2010

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

Vascular Solutions, Inc. and Shepherd Scientific, Inc. today announced they have entered into a distribution agreement providing for Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in the United States. The Angio Assist is an easy-to-use docking station that facilitates the introduction of guide wires into interventional devices including catheters and atherectomy burrs.

20 Sep 2010

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Athena™ programmer, a deep brain stimulation (DBS) therapy management system. This next-generation platform offers clinicians a powerful yet easy-to-use interface that enables them to set or adjust therapeutic parameters to optimize patient results.

20 Sep 2010

Boston Scientific announces acquisition of Asthmatx

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Asthmatx, Inc., a privately held company in Sunnyvale, California. Asthmatx designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma in the 6 to 8 million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications).

20 Sep 2010

$Neovasc commences enrollment in Reducer trial for refractory angina$

Neovasc commences enrollment in Reducer trial for refractory angina

Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.

20 Sep 2010

MultiStem multipotent adult progenitor cell therapy preserves 'blood brain barrier'

Athersys, Inc. announced today the publication of a key study in the October issue of Experimental Neurology conducted by researchers at Athersys, the University of Texas Medical School, the Michael E. DeBakey Institute for Comparative Cardiovascular Science and Biomedical Devices, and Texas A&M University.

20 Sep 2010

Oxygen Biotherapeutics announces CRADA Agreement amendment

Oxygen Biotherapeutics, Inc. today announced it has amended an existing Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Center (NMRC) to include preclinical trials using swine models to assess the safety and efficacy of Oxygen Biotherapeutics' proprietary Oxycyte perfluorocarbon emulsion (PFCE) for spinal cord injury (SCI) due to decompression sickness (DCS), and for hemorrhagic shock.

20 Sep 2010

Report: There’s nothing wrong with cosmetic surgery but beware of specialist qualifications

The report, released by the UK’s National Confidential Enquiry into Patient Outcome and Death (NCEPOD), warns patients that cosmetic surgery has not yet been recognised as a medical specialty and they should not rely on the recognised specialist qualifications of practitioners who perform cosmetic procedures.

19 Sep 2010

Scientists discover simple blood test for accurate diagnoses of liver damage

Scientists have discovered that the presence of specific proteins in the blood are indicative of early liver cell damage and can determine the point at which cell death occurred, the type of cell death, and the extent of any damage. This could lead to liver damage being assessed faster and more accurately in the future information which could prove valuable when treating people following drug overdoses.

18 Sep 2010

FDA grants Optovue 510(k) clearance on Normative Database for RTVue OCT device

Optovue, the company that launched the first FDA cleared fourier/spectral domain OCT in the U.S., announced that it has received 510(k) clearance on its Normative Database ("NDB") for the RTVue OCT device.

18 Sep 2010

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Elixir Medical Corporation, a developer of product platforms that combine innovative medical devices with potent pharmaceuticals for site-specific therapies, announced the initiation of patient enrollment in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir's next generation Novolimus Eluting Coronary Stent System (CSS) with bioabsorbable coating, the Elixir DESyne BD Novolimus Eluting CSS.

18 Sep 2010

$Study on role of SurgiCase Orthopaedics in correction of compound wrist fractures$

Study on role of SurgiCase Orthopaedics in correction of compound wrist fractures

Materialise announced that it would lend its considerable expertise in virtual surgical planning to researcher Dr. J. B. Jupiter, Chief Hand and Upper Extremity Service at Massachusetts General Hospital. Through an AO funded, IRB approved study, Dr. Jupiter will use SurgiCase(R) Orthopaedics to explore the advantages of computer-assisted surgery, virtual 3D planning and intra-operative use of patient-specific surgical guides in osteotomies to correct compound wrist fractures-the first research project of its kind.

17 Sep 2010

CID to provide update on Cre8 polymer-free DES program at TCT 2010

CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".

17 Sep 2010

Researchers find bariatric surgery reduces cardiovascular disease risk

Significant weight loss not only improves daily life of morbidly obese woman but also decreases the risk for cardiovascular disease (CVD). However, many people can not lose weight or can not maintain weight loss without help. Bariatric surgery is emerging as a valuable procedure to help morbidly obese individuals lose weight, as studies have shown; it can improve many health profiles and lower mortality. Now, researchers have found another positive impact of significant weight loss after bariatric surgery, it can significantly improve the lipoprotein profiles of women within a year following surgery.

17 Sep 2010

Medical Procedure News

Bariatric surgery rates rise among adolescents

New interventional technique effective for controlling hepatic arterial hemorrhage after PD

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

FG-4592 oral anemia therapy receives CTA approval from SFDA

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

Corindus announces clinical results of CorPath 200 System

New body-contouring laser causes fat loss

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

Boston Scientific announces acquisition of Asthmatx

Neovasc commences enrollment in Reducer trial for refractory angina

MultiStem multipotent adult progenitor cell therapy preserves 'blood brain barrier'

Oxygen Biotherapeutics announces CRADA Agreement amendment

Report: There’s nothing wrong with cosmetic surgery but beware of specialist qualifications

Scientists discover simple blood test for accurate diagnoses of liver damage

FDA grants Optovue 510(k) clearance on Normative Database for RTVue OCT device

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Study on role of SurgiCase Orthopaedics in correction of compound wrist fractures

CID to provide update on Cre8 polymer-free DES program at TCT 2010

Researchers find bariatric surgery reduces cardiovascular disease risk

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News